NCT07144592Recruiting
The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
Source: ClinicalTrials.gov · Last updated 27 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 6 Aug 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 25 Feb 2025
- Lead sponsor
- Muş Alparslan University
- Diseases
- Schizophrenia
- NCT number
- NCT07144592
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jan 2025 to the primary completion date, 25 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- those who do not meet the inclusion criteria
Who the study is looking for
- Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
- Being between 18 and 65 years of age,
- Being literate and verbally communicative,
- Being clinically stable (not exhibiting symptoms of acute psychosis),
- Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
- Being cognitively competent enough to participate in individual interviews during the research process,
- Being an individual currently receiving psychiatric treatment and taking medication,
- Agreeing to participate voluntarily in the study and signing a written informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Community Mental Health Center Coordinator of this site? Confirm its status | Muş | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.